Symptomatische therapie-refraktäre myokardischämie bei koronarer herzkrankheit: Chronisch-intermittierende urokinasetherapie und invasive therapieverfahren

Internist

Volumn 37, Issue 6, 1996, Pages 597-606

  Leschke, M ^a   Schoebel, F C ^a   Strauer, B E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN; UROKINASE; FIBRINOLYTIC AGENT;

ANGINA PECTORIS; BLOOD RHEOLOGY; CLASSIFICATION; CORONARY ARTERY DISEASE; DISEASE SEVERITY; HEART MUSCLE ISCHEMIA; HUMAN; MORBIDITY; MORTALITY; REVIEW; ADULT; AGED; CLINICAL TRIAL; CORONARY ARTERY THROMBOSIS; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; FIBRINOLYTIC THERAPY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CLINICAL TRIALS; COMBINED MODALITY THERAPY; CORONARY DISEASE; CORONARY THROMBOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; SURVIVAL RATE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0030163868     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Banerjee AK, Pearson J, Gilliland EL et al. (1992) A six year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants. Thromb Haemost 68:261
2. Bär FW, Verbeugt FW, Col J et al. (1992) Thrombolysis in patients with unstable angina improves angiographic but not clinical outcome: results of UNASEM, a multicenter, randomized, placebo-controlled, clinical trial with anistreplase. Circulation 86:131
3. Benson H, Mc Callie DP Jr (1979) Angina pectoris and the placebo effect. N Engl J Med 300:1424
4. Bini A, Fenoglia JJ, Mesa-Tejada R, Kudryk B, Kaplan KL (1989) Identification and distribution of fibrinogen, fibrin and fibrin(ogen) degradation products in atherosclerosis: use of monoclonal antibody. Arteriosclerosis 9:109
5. Braunwald E, Jones RH, Mark DB, Brown J, Cheitlin MD, Concannas CA, Cohan M, Edwards C, Fuster V, Goldman L, Green LA, Grihes C, Lytle BW, Mc Cauley KM, Mushlin AI, Rose GC, Smith EE, Swain JA, Topol EJ, Willerson JT (1989) Diagnosing and managing unstable angina. Circulation 90:613
6. Broadhurst P, Kellner C, Hughes L, Imeson JD, Raftery EB (1990) Fibrinogen, factor VII clotting activity and coronary artery disease activity. Atherosclerosis 85:169
7. Chamberlain DA (1989) Unanswered questions in thrombolysis. Am J Cardiol 63:34A
8. Campeau L (1976) Grading of angina pectoris. Circulation 54:522
9. Ceriello A, Pirsisi M, Giacornello R, Stel G, Falleti E, Motz E (1994) Fibrinogen plasma levels as a marker of thrombin activation: New insights on the role of fibrinogen as a cardiovascular risk factor. Thromb Haemost 71:593
10. Chien S (1987) Physiological and pathophysiological significance of hemorheology. In: Chien S, Dormandy J, Ernst E, Mattrai A (eds) Clinical hemorheology. Nijhoff, Dordrecht, p 125
11. Davies MJ, Thomas AC, Knapman PA, Hangartner JR (1986) Inramyocardial patelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 73:418
12. Davies MJ, Bland JM, Hangartner JRW, Angelini A, Thomas AC (1989) Factors influencing the presence or absence of acute coronary syndromes in sudden ischemic death. Eur Heart J 10:203
13. Ehrly AM, Schenk JF (1987) Systemisch niedrigdosierte Langzeit-Urokinasetherapie bei schwerster Angina pectoris. Grundlagen und erste Ergebnisse. In: Strauer BE, Ehrly AM, Leschke M (Hrsg) Fortschritte in der kardiovaskulären Rheologie. Münchner Wissenschaftliche Publikation, München, S 35
14. Falk E (1985) Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death: autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in vascular occlusion. Circulation 71:699
15. Fitzgerald DJ, Catella F, Roy L, FitzGerald GA (1988) Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation 77:142
16. 2 modulate the response to tissue-type plasminogen activator in vivo. Circ Res 1 65:83
17. Fuster V, Badimon L, Badimon J, Chesebro J (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts). N Engl J Med 326:242
18. Fuster V, Badimon L, Badimon J, Chesebro J (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (second of two parts). N Engl J Med 326:310
19. Gleichmann U, Mannebach H, Lichtlen P (1995) Bericht über Struktur und Leistungszahlen der Herzkatheterlabors in der Bundesrepublik Deutschland. Z Kardiol 4:327
20. Gordon RJ, Snyder GK, Tritel H, Taylor WJ (1974) Potential significance of plasma viscosity and hematocrit variations in myocardial ischemia. Am Heart J 87:175
21. Gulba DC, Barthels M, Westhoff-Bleck M, Jost S, Raffenbeul W, Daniel WG, Hecker H, Lichtlen PR (1991) Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Circulation 83:937
22. Hoffmann JJML (1990) Blood viscosity and platelet function in thrombolytic therapy of acute myocardial infarction. Eur Heart J 11 [Suppl F]:29
23. Jan KM (1985) Altered Theological properties of blood following administration of tissue plasminogen activator and streptokinase in patients with acute myocardial infarction. Circulation 72 [Suppl III]:417
24. Kaiser GC, Davies KB, Fisher LD, Myers WO, Foster E, Passamani ER, Gillespie MJ (1985) Survival following coronary bypass grafting in patients with severe angina pectoris (CASS). J Thorac Cardiovasc Surg 89:13
25. Kleophas W, Leschke M, Tschöpe D, Martin J, Schauseil S, Schottenfeld Y, Strauer BE, Gries FA (1990) Akute Wirkungen der extrakorporalen LDL-Cholesterin- und Fibrinogen-Elimination auf Blutrheologie und Mikrozirkulation. Dtsch Med Wochenschr 115:3
26. Koenig W, Ernst E (1992) The possible role of hemorheology in atherothrombogenesis. Atherosclerosis 94:93
27. Leschke M, Blanke H, Stellwaag M, Motz W, Strauer BE (1988) Hyperfibrinogenämie und pathologische Plasmaviskosität. Dtsch Med Wochenschr 113:1175
28. Leschke M, Höffken H, Schmidtdorff A, Blanke H, Egbring R, Joseph U, Strauer BE (1989) Einfluß von Fenofibrat auf Fibrinogenkonzentration und Blutflußindität. Konsequenzen für die myokardiale Mikrozirkulation der koronaren Herzkrankheit? Dtsch Med Wochenschr 114:939
29. Leschke M, Strauer BE (1990) Die Bedeutung rheologischer Mechanismen in der Atherogenese. Arzneimittelforschung Drug Res 40:356
30. Leschke M, Höffken H, Motz W, Blanke H, Schoebel FC, Strauer BE (1992) Chronisch-intermittierende Urokinasetherapie bei therapierefraktärer Angina pectoris. Dtsch Med Wochenschr 117:81
31. Leschke M, Schoebel FC, Mecklenbeck W, Stein D, Jax TW, Müller-Gärtner HW, Strauer BE (1996) Long-term-intermitten urokinase therapy in patients with endstage coronary artery disease and refractory angina pectoris: a randomized dose responce trial. J Am Coll Cardiol 27:575
32. Mannheimer C, Eliasson T, Andersson B, Bergh C-H, Augustinsson LE, Emanuelsson H, Waagstein F (1993) Effects of spinal cord stimulation on angina pectoris induced by pacing and possible mechanisms of action. Br Med J 307:477
33. Melandri G, Semprini F, Cervi V, Candiotti N, Palazzini E, Branzi A, Magnami B (1993) Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris: a double-blind randomized, placebo-controlled trial. Circulation 88:2517
34. Mirhoseini M, Shelgikar S, Cayton M (1990) Clinical and histological evaluation of laser myocardial revascularization. J Clin Laser Med Surg 9:73
35. Moriarty AJ (1988) Streptokinase and reduced plasma viscosity: a second benefit. Eur J Haematol 41:25
36. Quyyumi AA, Divdati JG, Lakatos EE, Bonow RO, Epstein SE (1993) Angiogenic effects of low molecular weight heparin in patients with stable coronary artery disease: a pilot study. J Am Coll Cardiol 22:635
37. Rapold HJ (1990) Promotion of thrombin activity by thrombolytic therapy without simultaneous anticoagulation. Lancet 1:481
38. Romeo F, Rosano G MC, Martuscelli E, Comito M, Cardona N, Colistra C, Milano B, Bianco C, Rosano V (1995) Effectiveness of prolonged low does recombinant tissue-type plasminogen activator for refractory unstable angina. J Am Coll Cardiol 25:1295
39. Schmid-Schönbein H (1981) Interaction of vasomotion and blood rheology in hemodynamics. In: Lowe GDO, Barbend JC, Forbes CD (eds) Clinical aspects of blood viscosity and red cell deformability. Springer, Berlin Heidelberg New York, p 49
40. Schmid-Schönbein H (1981) Myokardiale Mikrozirkulation. Wechselwirkung zwischen Vasomotorik und Fließeigenschaften des Blutes. Dtsch Med Wochenschr 106:1483
41. Schneidau A, Harrison MJG, Hurst C, Wilkers HC, Meade TW (1989) Arterial disease risk factors and angiographic evidence of atheroma of the carotid artery. Stroke 20:1466
42. Schoebel FC, Jax TW, Leschke M, Strauer BE (1995) Theapierefraktäre Angina pectoris bei koronarer Herzkrankheit - Ein Koronarsyndrom mit intensivmedizinischer Bedeutung. Intensivmedizin 32:552
43. Schoebel FC, Stein D, Heins M, Heintzen M, Leschke M, Strauer BE (1995) Systemische Thrombolyse bei instabiler Angina pectoris - Neue Aspekte bei therapierefraktären Patienten. Perfusion 8:324
44. Schoebel FC, Leschke M, Stein D, Heins M, Pels K, Jax TW, Strauer BE (1995) Chronic-Intermittent urokinase therapy in refractory angina pectoris. Fibrinolysis 9 [Suppl 1]:121
45. Schoebel FC, Leschke M, Strauer BE (1995) Therapierefraktäre Angina pectoris - pathophysiologische Grundlagen und alternative Therapieansätze. Dtsch Med Wochenschr 120:301
46. Schreiber TL, Rizik D, White C, Sham GVRK, Cowley M, Macina G, Reddy PS, Kantoumis L, Timmis GC, Margulis A, Bunnell P, Barker W, Sasahara A (1992) Randomized trial of thrombolysis versus heparin in unstable angina. Circulation 86:1407
47. Smith EB, Keen AG, Grant A, Stirk C (1990) Fate of fibrinogen in human aterial intima. Atherosclerosis 10:263
48. The TIMI IIIb Investigators (1994) Effects of tissue plasminogen activators and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results from the TIMI IIIb trial. Circulation 89:1545
49. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW (1995) For the European Concerted Action on Thrombosis and Disabilities Angina pectoris Study Group. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 332:635
50. Wolf R, Lichtlen PR (1995) Die Beziehung zwischen Plasmafibrinogen und der Funktion der Kollateralgefaße. Z Kardiol 84:348